Natural Peptide Toxins as an Option for Renewed Treatment of Type 2 Vasopressin Receptor-Related Diseases
The type 2 vasopressin receptor (V2R) is expressed in the kidneys, and it is the keystone of water homeostasis. Under the control of the antidiuretic hormone vasopressin, the V2R ensures vital functions, and any disturbance has dramatic consequences. Despite decades of research to develop drugs capa...
Main Author: | Nicolas Gilles |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/4/544 |
Similar Items
-
Vasopressin receptor antagonists and their role in clinical medicine
by: Girish Narayen, et al.
Published: (2012-01-01) -
Activation of polycystin-1 signaling by binding of stalk-derived peptide agonists
by: Shristi Pawnikar, et al.
Published: (2024-10-01) -
Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
by: Helbert Rondon-Berrios, et al.
Published: (2017-08-01) -
Human Peptides α-Defensin-1 and -5 Inhibit Pertussis Toxin
by: Carolin Kling, et al.
Published: (2021-07-01) -
Inappropriate Arginine Vasopressin Levels and Hyponatremia Associated with Cyclic Vomiting Syndrome
by: Anders Breinbjerg, et al.
Published: (2015-01-01)